CAS 2275619-53-7

Formule : C21H16BrCl2FN2O6S2

InChI : InChI=1S/C21H16BrCl2FN2O6S2/c1-11-5-18(25)17(22)10-19(11)27-35(31,32)20-4-3-14(9-16(20)21(28)33-2)26-34(29,30)15-7-12(23)6-13(24)8-15/h3-10,26-27H,1-2H3

Code InChI : FKFQBYBODAKGOA-UHFFFAOYSA-N

SMILES : CC1=CC(=C(C=C1NS(=O)(=O)C2=C(C=C(C=C2)NS(=O)(=O)C3=CC(=CC(=C3)Cl)Cl)C(=O)OC)Br)F

MDL-800

CAS : 2275619-53-7

MDL-800

Formule : C₂₁H₁₆BrCl₂FN₂O₆S₂

Degré de pureté : ≥98%

Masse moléculaire : 626.3

Ref: 54-BUP02971

MDL 800

CAS : 2275619-53-7

Formule : C₂₁H₁₆BrCl₂FN₂O₆S₂

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 626.2999

Ref: IN-DA01JK71

MDL-800

CAS : 2275619-53-7

MDL-800

Formule : C₂₁H₁₆BrCl₂FN₂O₆S₂

Degré de pureté : 98%

Masse moléculaire : 626.29994

Ref: 54-BISN0090

MDL 800

CAS : 2275619-53-7

Methyl 2-(N-(5-bromo-4-fluoro-2-methylphenyl)sulfamoyl)-5-(3,5-dichlorophenylsulfonamido)benzoate

Formule : C₂₁H₁₆BrCl₂FN₂O₆S₂

Degré de pureté : 98%

Masse moléculaire : 626.3

Ref: IN-DG01074152

MDL-800

CAS : 2275619-53-7

MDL-800 is a SIRT6 modulator with antitumor activity for the study of hepatocellular carcinoma and non-small cell lung cancer.

Formule : C₂₁H₁₆BrCl₂FN₂O₆S₂

Degré de pureté : 99.95% - 99.96%

Couleur et forme : White Solid

Masse moléculaire : 626.3

Ref: TM-T64529

METHYL 2-(N-(5-BROMO-4-FLUORO-2-METHYLPHENYL)SULFAMOYL)-5-(3,5-DICHLOROPHENYLSULFONAMIDO)BENZOATE

CAS : 2275619-53-7

Degré de pureté : 98%

Masse moléculaire : 626.289978

Ref: 10-F861410

MDL 800

CAS : 2275619-53-7

Allosteric activator of SIRT6, mediated by increasing the affinity of acetylated substrates and cofactors and increasing the efficiency of its deacetylase activity. Has anti-proliferative activity in hepatocellular carcinoma (HCC) cells in vitro and reduces tumor growth in xenograft models in vivo.

Formule : C₂₁H₁₆BrCl₂FN₂O₆S₂

Degré de pureté : Min. 95%

Masse moléculaire : 626.3 g/mol

Ref: 3D-BM167528